Literature DB >> 23314828

Natural history of cirrhosis.

Sumeet K Asrani1, Patrick S Kamath.   

Abstract

Significant strides have been made in the last few years in advancing our knowledge of the natural history of cirrhosis. These include (1) a better understanding of prognosis in compensated and decompensated cirrhosis, (2) improved estimates of the natural course of variceal bleeding in patients receiving standard of care therapy, (3) recognition of renal failure and infection as important determinants of mortality in the clinic course, (4) realization of the importance of hepatic venous pressure gradient as a marker of prognosis, progression, and treatment response, and (5) evolution of noninvasive studies of liver stiffness as potential predictors of decompensation. Further studies identifying cirrhotics at highest risk of transitioning from a compensated state to a decompensated state will be important in order to alter the natural history of cirrhosis.

Entities:  

Mesh:

Year:  2013        PMID: 23314828     DOI: 10.1007/s11894-012-0308-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  47 in total

1.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Arun J Sanyal; Norman D Grace; William Carey
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

2.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.

Authors:  Francesco Vizzutti; Umberto Arena; Roberto G Romanelli; Luigi Rega; Marco Foschi; Stefano Colagrande; Antonio Petrarca; Stefania Moscarella; Giacomo Belli; Anna Linda Zignego; Fabio Marra; Giacomo Laffi; Massimo Pinzani
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

3.  Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

Authors:  Laurent Huwart; Christine Sempoux; Eric Vicaut; Najat Salameh; Laurence Annet; Etienne Danse; Frank Peeters; Leon C ter Beek; Jacques Rahier; Ralph Sinkus; Yves Horsmans; Bernard E Van Beers
Journal:  Gastroenterology       Date:  2008-04-04       Impact factor: 22.682

4.  Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.

Authors:  Cristina Ripoll; Rafael Bañares; Diego Rincón; María-Vega Catalina; Oreste Lo Iacono; Magdalena Salcedo; Gerardo Clemente; Oscar Núñez; Ana Matilla; Luis-Miguel Molinero
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

5.  Incidence and natural history of small esophageal varices in cirrhotic patients.

Authors:  Manuela Merli; Giorgia Nicolini; Stefania Angeloni; Vittorio Rinaldi; Adriano De Santis; Carlo Merkel; Adolfo Francesco Attili; Oliviero Riggio
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

6.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

7.  Prognostic value of early measurements of portal pressure in acute variceal bleeding.

Authors:  E Moitinho; A Escorsell; J C Bandi; J M Salmerón; J C García-Pagán; J Rodés; J Bosch
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

8.  Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.

Authors:  M Lemoine; S Katsahian; M Ziol; P Nahon; N Ganne-Carrie; F Kazemi; V Grando-Lemaire; J-C Trinchet; M Beaugrand
Journal:  Aliment Pharmacol Ther       Date:  2008-11-01       Impact factor: 8.171

9.  Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment.

Authors:  M Michele Manos; Wendy A Leyden; Rosemary C Murphy; Norah A Terrault; Beth P Bell
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

Review 10.  Prognostic markers in patients with cirrhosis and portal hypertension who have not bled.

Authors:  Maria Poca; Angela Puente; Isabel Graupera; Càndid Villanueva
Journal:  Dis Markers       Date:  2011       Impact factor: 3.434

View more
  24 in total

1.  Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.

Authors:  Sonam Vadera; Charles Wei Kit Yong; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2019-06-20

2.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

3.  The consequences of cirrhosis in America.

Authors:  Syed-Mohammed R Jafri; Stuart C Gordon
Journal:  Dig Dis Sci       Date:  2015-02       Impact factor: 3.199

Review 4.  Farnesoid X receptor: a potential therapeutic target in multiple organs.

Authors:  Chao Zhang; Zixuan Wang; Qingqing Feng; Wei-Dong Chen; Yan-Dong Wang
Journal:  Histol Histopathol       Date:  2021-01-04       Impact factor: 2.303

Review 5.  Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?

Authors:  Kyung-Hyun Kim; Kwan-Kyu Park
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

6.  T1 mapping for liver function evaluation in gadoxetic acid-enhanced MR imaging: comparison of look-locker inversion recovery and B1 inhomogeneity-corrected variable flip angle method.

Authors:  Ji Eun Kim; Hyun Ok Kim; Kyungsoo Bae; Dae Seob Choi; Dominik Nickel
Journal:  Eur Radiol       Date:  2019-03-22       Impact factor: 5.315

Review 7.  Value of Liver Function Tests in Cirrhosis.

Authors:  Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2021-11-14

Review 8.  Bone marrow derived stem cells for the treatment of end-stage liver disease.

Authors:  Cristina Margini; Ranka Vukotic; Lucia Brodosi; Mauro Bernardi; Pietro Andreone
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

9.  Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis.

Authors:  Melisa Dirchwolf; Andrés Eduardo Ruf
Journal:  World J Hepatol       Date:  2015-08-08

10.  Reduction in SNAP-23 Alters Microfilament Organization in Myofibrobastic Hepatic Stellate Cells.

Authors:  Haleigh B Eubanks; Elise G Lavoie; Jessica Goree; Jeffrey A Kamykowski; Neriman Gokden; Michel Fausther; Jonathan A Dranoff
Journal:  Gene Expr       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.